T. Fujita

T. Fujita, K. Sugano, Soichiro Ito, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System

T. Fujita, Kazuo Takayama, Ryosuke Negoro, 2022, Cells.

Functional linkage of H+/peptide transporter PEPT2 and Na+/H+ exchanger in primary cultures of astrocytes from mouse cerebral cortex

T. Fujita, A. Yamamoto, N. Okada, 2005, Brain Research.

Functional Expression of Taurine Transporter and its Up-Regulation in Developing Neurons from Mouse Cerebral Cortex

T. Fujita, A. Yamamoto, Ayumi Shimada, 2006, Pharmaceutical Research.

Involvement of transporter recruitment as well as gene expression in the substrate-induced adaptive regulation of amino acid transport system A.

V. Ganapathy, T. Fujita, P. Prasad, 2001, Biochimica et biophysica acta.

Role of nuclear factor-κB in gastric ulcer healing in rats

T. Fujita, Satoru Takahashi, A. Yamamoto, 2001 .

Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras.

V. Ganapathy, T. Fujita, Y. Fei, 1998, Biochemical and biophysical research communications.

Development of magnetic anionic liposome/atelocollagen complexes for efficient magnetic drug targeting

T. Fujita, Y. Kono, Taketo Nakai, 2017, Drug delivery.

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs

T. Fujita, A. Yamamoto, Y. Kono, 2021, Pharmaceutics.

Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice

T. Mayumi, H. Mizuguchi, T. Hayakawa, 2003, Gene Therapy.

Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector

S. Nakagawa, H. Mizuguchi, T. Fujita, 2006, Cancer Gene Therapy.

Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors

H. Mizuguchi, T. Hayakawa, T. Fujita, 2003, Cancer Gene Therapy.

Tissue distribution of 111In-labeled uricase conjugated with charged dextrans and polyethylene glycol.

M. Hashida, T. Fujita, Y. Takakura, 1991, Journal of pharmacobio-dynamics.

Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice

M. Hashida, F. Yamashita, T. Fujita, 1992 .

Tumor Necrosis Factor α‐Gene Therapy for an Established Murine Melanoma Using RGB (Arg‐Gly‐Asp) Fiber‐mutant Adenovirus Vectors

S. Nakagawa, T. Mayumi, H. Mizuguchi, 2002, Japanese journal of cancer research : Gann.

Absorption of water-soluble compounds with different molecular weights and.

T. Fujita, A. Yamamoto, S. Muranishi, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.

T. Fujita, A. Yamamoto, N. Okada, 2001, The Journal of pharmacology and experimental therapeutics.

Enhanced Permeability of Insulin across the Rat Intestinal Membrane by Various Absorption Enhancers: Their Intestinal Mucosal Toxicity and Absorption‐enhancing Mechanism of n‐Lauryl‐β‐D‐maltopyranoside

T. Fujita, A. Yamamoto, Y. Quan, 1999, The Journal of pharmacy and pharmacology.

Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.

T. Fujita, A. Yamamoto, S. Muranishi, 1998, Journal of pharmaceutical sciences.

Pulmonary absorption enhancement of peptides by absorption enhancers and protease inhibitors

T. Fujita, A. Yamamoto, S. Muranishi, 1996 .

Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.

T. Fujita, A. Yamamoto, Y. Quan, 1996, Journal of pharmaceutical sciences.

Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.

T. Fujita, A. Yamamoto, S. Muranishi, 1995, Journal of pharmaceutical sciences.

Susceptibility of ebiratide to proteolysis in rat intestinal fluid and homogenates and its protection by various protease inhibitors.

T. Fujita, A. Yamamoto, S. Muranishi, 1994, Life sciences.

Gabapentin Blocks L-Type and P/Q-Type Ca2+ Channels Involved in Depolarization-Stimulated Nitric Oxide Synthase Activity in Primary Cultures of Neurons from Mouse Cerebral Cortex

Y. Itoh, T. Fujita, A. Yamamoto, 2003, Pharmaceutical Research.

A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices

Y. Itoh, T. Fujita, A. Yamamoto, 2003, British journal of pharmacology.

sigma Receptor ligand-induced up-regulation of the H(+)/peptide transporter PEPT1 in the human intestinal cell line Caco-2.

V. Ganapathy, T. Fujita, F. Leibach, 1999, Biochemical and biophysical research communications.

Transport Characteristics of 5-Aminosalicylic Acid Derivatives Conjugated with Amino Acids via Human H+-Coupled Oligopeptide Transporter PEPT1.

T. Fujita, S. Miyauchi, T. Terada, 2020, Biological & pharmaceutical bulletin.

Pharmacokinetic analysis of scavenger receptor-mediated uptake of anionized proteins in the isolated perfused rat liver

M. Hashida, F. Yamashita, T. Fujita, 1997 .

Hepatic targeting of proteins utilizing carbohydrate recognition mechanism.

M. Hashida, T. Fujita, M. Nishikawa, 1991 .

FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils.

T. Fujita, A. Yamamoto, S. Takahashi, 2001, The Journal of pharmacology and experimental therapeutics.

Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.

M. Hashida, T. Fujita, Y. Takakura, 1992, The Journal of pharmacology and experimental therapeutics.

Enhanced permeability of phenylalanyl-glycine (Phe-Gly) across the intestinal membranes by chemical modification with various fatty acids.

T. Fujita, A. Yamamoto, S. Muranishi, 2003, Drug metabolism and pharmacokinetics.

Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implication of high affinity type H+/peptide transporter PEPT2 mediated transport system

V. Ganapathy, T. Fujita, A. Yamamoto, 1999, Neuroscience Letters.

Enhancement of the small intestinal uptake of phenylalanylglycine via a H+/oligopeptide transport system by chemical modification with fatty acids.

T. Fujita, A. Yamamoto, S. Muranishi, 1997, Life sciences.

Functional expression and adaptive regulation of Na+-dependent neutral amino acid transporter SNAT2/ATA2 in normal human astrocytes under amino acid starved condition

T. Fujita, A. Yamamoto, Kazunari Tanaka, 2005, Neuroscience Letters.

Synthesis and Pharmacokinetics of a New Liver-Specific Carrier, Glycosylated Carboxymethyl-Dextran, and Its Application to Drug Targeting

M. Hashida, T. Fujita, Y. Takakura, 2004, Pharmaceutical Research.

Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion.

M. Hashida, T. Fujita, Y. Takakura, 1992, Biochemical and biophysical research communications.

Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade.

Y. Itoh, T. Fujita, M. Oka, 2002, European journal of pharmacology.

Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.

T. Fujita, G. Fetih, H. Katsumi, 2006, Drug metabolism and pharmacokinetics.

Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.

T. Fujita, G. Fetih, A. Yamamoto, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Magnetization of mesenchymal stem cells using magnetic liposomes enhances their retention and immunomodulatory efficacy in mouse inflamed skeletal muscle.

S. Fujita, T. Fujita, Koji Matsuda, 2021, International journal of pharmaceutics.

Functional characterization of Na+-coupled citrate transporter NaC2/NaCT expressed in primary cultures of neurons from mouse cerebral cortex

T. Fujita, Ayumi Shimada, Miyuki Wada, 2006, Brain Research.

Control of pharmaceutical properties of soybean trypsin inhibitor by conjugation with dextran. I: Synthesis and characterization.

M. Hashida, T. Fujita, Y. Takakura, 1989, Journal of pharmaceutical sciences.

Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.

T. Fujita, A. Yamamoto, S. Muranishi, 1999, Life sciences.

Involvement of the renal kallikrein-kinin system in furosemide-induced natriuresis in rats.

T. Fujita, Y. Kumagai, M. Majima, 2000, Japanese journal of pharmacology.

Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2

T. Nakanishi, T. Fujita, I. Tamai, 2012, PloS one.

Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. I. Possible factors for the low oral bioavailability in rats.

T. Fujita, A. Yamamoto, S. Muranishi, 1994, Biological & pharmaceutical bulletin.

Validation of a Pharmacokinetic Model of Colon‐specific Drug Delivery and the Therapeutic Effects of Chitosan Capsules Containing 5‐Aminosalicylic Acid on 2,4,6‐Trinitrobenzenesulphonic Acid‐induced Colitis in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1999, The Journal of pharmacy and pharmacology.

Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.

T. Fujita, A. Yamamoto, S Muranishi, 1998, Biological & pharmaceutical bulletin.

Effectiveness and Toxicity Screening of Various Absorption Enhancers in the Rat Small Intestine: Effects of Absorption Enhancers on the Intestinal Absorption of Phenol Red and the Release of Protein and Phospholipids from the Intestinal Membrane

T. Fujita, A. Yamamoto, S. Muranishi, 1996, The Journal of pharmacy and pharmacology.

Increased oxidative stress in obesity and its impact on metabolic syndrome.

Morihiro Matsuda, Makoto Makishima, Masanori Iwaki, 2004, The Journal of clinical investigation.

Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate.

V. Ganapathy, T. Fujita, Y. Fei, 1998, The Journal of biological chemistry.

Cloning and Functional Expression of a cDNA Encoding a Mammalian Sodium-dependent Vitamin Transporter Mediating the Uptake of Pantothenate, Biotin, and Lipoate*

V. Ganapathy, T. Fujita, Haiping Wang, 1998, The Journal of Biological Chemistry.

A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection

S. Nakagawa, T. Fujita, N. Okada, 2008, Journal of Controlled Release.

Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.

Akira Yamamoto, Yulian Lin, T. Fujita, 2008, The Journal of pharmacy and pharmacology.

Intradermal concentration of hydroquinone after application of hydroquinone ointments is higher than its cytotoxic concentration.

T. Fujita, T. Sakaeda, K. Nishiguchi, 2003, Biological & pharmaceutical bulletin.

Effects of various storage conditions and alterations of antioxidant contents on chromatic aberration of hydroquinone ointment.

M. Ichihashi, J. Nordlund, T. Fujita, 2003, Biological & pharmaceutical bulletin.

Pharmaceutical and clinical assessment of hydroquinone ointment prepared by extemporaneous nonsterile compounding.

M. Hirai, M. Ichihashi, J. Nordlund, 2002, Biological & pharmaceutical bulletin.

Chitosan oligomers as potential and safe absorption enhancers for improving the pulmonary absorption of interferon-alpha in rats.

T. Fujita, M. Odomi, A. Yamamoto, 2005, Journal of pharmaceutical sciences.

Functional and molecular identification of sodium‐coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons

V. Ganapathy, T. Fujita, A. Yamamoto, 2006, Journal of neurochemistry.

Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.

T. Fujita, H. Katsumi, A. Yamamoto, 2008, International journal of pharmaceutics.

Improvement of pulmonary absorption of insulin and other water-soluble compounds by polyamines in rats.

T. Fujita, H. Katsumi, A. Yamamoto, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP

K. Maeda, H. Kusuhara, Y. Sugiyama, 2012, British journal of pharmacology.

Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats

Akira Yamamoto, T. Fujita, A. Yamamoto, 1994, Pharmaceutical Research.

CC‐chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor‐infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma

S. Nakagawa, T. Fujita, N. Okada, 2007, International journal of cancer.

Glucosamine induces lipid accumulation and adipogenic change in C2C12 myoblasts.

M. Matsuda, I. Shimomura, Kentaro Morita, 2005, Biochemical and biophysical research communications.

Generation of Caco-2 cells stably expressing CYP3A4·POR·UGT1A1 and CYP3A4·POR·UGT1A1*6 using a PITCh system

T. Fujita, Y. Kono, Ryosuke Negoro, 2021, Archives of Toxicology.

Functional characterization and cloning of amino acid transporter B0,+ (ATB0,+) in primary cultured rat pneumocytes

V. H. Lee, T. Fujita, Z. Borok, 2008, Journal of cellular physiology.

Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants.

S. Nakagawa, H. Mizuguchi, T. Fujita, 2008, Virology.

Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells

H. Mizuguchi, T. Hayakawa, T. Fujita, 2007, Gene Therapy.

Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.

Akira Yamamoto, T. Fujita, A. Yamamoto, 2004, Journal of pharmaceutical sciences.

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors.

T. Mayumi, H. Mizuguchi, T. Hayakawa, 2001, Biochemical and biophysical research communications.

Impact of degree of supersaturation on the dissolution and oral absorption behaviors of griseofulvin amorphous solid dispersions

T. Fujita, K. Kawakami, Masafumi Fukiage, 2020 .

Colon-specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules

T. Fujita, A. Yamamoto, H. Tozaki, 2000 .

Relevance of Liquid-Liquid Phase Separation of Supersaturated Solution in Oral Absorption of Albendazole from Amorphous Solid Dispersions

T. Fujita, K. Kawakami, Masafumi Fukiage, 2021, Pharmaceutics.

Inhibition of Liquid–Liquid Phase Separation for Breaking the Solubility Barrier of Amorphous Solid Dispersions to Improve Oral Absorption of Naftopidil

T. Fujita, K. Kawakami, Masafumi Fukiage, 2022, Pharmaceutics.

Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.

T. Mayumi, H. Mizuguchi, T. Hayakawa, 2001, Cancer research.

Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens

S. Nakagawa, T. Mayumi, T. Fujita, 2001, British Journal of Cancer.

Use of Protease Inhibitors to Improve Calcitonin Absorption from the Small and Large Intestine in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1998, The Journal of pharmacy and pharmacology.

Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy.

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 2004, Biochemical and biophysical research communications.

Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol.

M. Hashida, T. Fujita, Y. Takakura, 1990, Chemical & pharmaceutical bulletin.

Enhancement of intestinal transport of thyrotropin-releasing hormone via a carrier-mediated transport system by chemical modification with lauric acid.

T. Fujita, A. Yamamoto, Y. Yamamoto, 1996, Biochimica et biophysica acta.

Indigo enhances wound healing activity of Caco-2 cells via activation of the aryl hydrocarbon receptor

Toshinori Sawano, T. Fujita, Chisa Takagi, 2021, Journal of Natural Medicines.

Transport characteristics of N‐acetyl‐l‐aspartate in rat astrocytes: involvement of sodium‐coupled high‐affinity carboxylate transporter NaC3/NaDC3‐mediated transport system

V. Ganapathy, T. Fujita, A. Yamamoto, 2005, Journal of neurochemistry.

Improvement of intestinal absorption of azetirelin, a new TRH analogue, by absorption enhancers.

T. Fujita, A. Yamamoto, S. Muranishi, 1994 .

Effects of rabbit gastrointestinal mucins and dextran on hydrochloride diffusion in vitro.

T. Fujita, K. Saigenji, K. Hotta, 2000, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

Nonsteroidal anti-inflammatory drug-induced acute gastric injury in Helicobacter pylori gastritis in Mongolian gerbils.

T. Fujita, A. Yamamoto, S. Takahashi, 2000, European journal of pharmacology.

Pharmaceutical stability of colloidal saccharated iron oxide injection in normal saline

T. Fujita, D. Hira, Tomonobu Okano, 2018, Journal of pharmaceutical health care and sciences.

ς Receptor Ligand-Induced Up-Regulation of the H+/Peptide Transporter PEPT1 in the Human Intestinal Cell Line Caco-2

V. Ganapathy, T. Fujita, A. Yamamoto, 1999 .

Urinary Metabolic Fingerprinting for α-naphthylisothiocyanate-induced Intrahepatic Cholestasis in Rats Using Fourier Transform-ion Cyclotron Resonance Mass Spectrometry

T. Fujita, S. Takenaka, M. Ide, 2008, Toxicologic pathology.

Control of in vivo fate of albumin derivatives utilizing combined chemical modification.

M. Hashida, T. Fujita, Y. Takakura, 1994, Journal of drug targeting.

Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs

T. Fujita, K. Sugano, Naoya Matsumura, 2020, Pharmaceutics.

Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using Xenopus pulmonary membrane.

T. Fujita, H. Tanaka, A. Yamamoto, 2001, Biological and Pharmaceutical Bulletin.

Stability of Acyl Derivatives of Insulin in the Small Intestine: Relative Importance of Insulin Association Characteristics in Aqueous Solution

T. Fujita, A. Yamamoto, S. Muranishi, 1994, Pharmaceutical Research.

Development of New Lipophilic Derivatives of Tetragastrin: Physicochemical Characteristics and Intestinal Absorption of Acyl-tetragastrin Derivatives in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1993, Pharmaceutical Research.

Potential for lymphatic targeting of peptides

T. Fujita, A. Yamamoto, S. Muranishi, 1997 .

Role of nuclear factor-kappaB in gastric ulcer healing in rats.

T. Fujita, A. Yamamoto, S. Takahashi, 2001, American journal of physiology. Gastrointestinal and liver physiology.

Functional characterization of Na+-independent choline transport in primary cultures of neurons from mouse cerebral cortex

T. Fujita, A. Yamamoto, N. Okada, 2006, Neuroscience Letters.

Electrophysiological studies on the mechanism for enhanced intestinal transport of water-soluble compounds by antibiotic peptide bacitracin.

T. Fujita, A. Yamamoto, Y. Quan, 1999, Biological & pharmaceutical bulletin.

Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.

Akira Yamamoto, Xuehua Jiang, Yulian Lin, 2007, Biological & pharmaceutical bulletin.

Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan

T. Fujita, K. Sugano, Naoya Matsumura, 2019, ADMET & DMPK.

Mesenchymal Stem Cells Alter the Inflammatory Response of C2C12 Mouse Skeletal Muscle Cells.

T. Fujita, Y. Kono, Ryosuke Negoro, 2020, Biological & pharmaceutical bulletin.

Effects of oral administration of collagen peptides on skin collagen content and its underlying mechanism using a newly developed low collagen skin mice model

T. Fujita, K. Matsunaga, A. Haratake, 2015 .

Role of cyclooxygenase-2 in Helicobacter pylori- induced gastritis in Mongolian gerbils.

T. Fujita, A. Yamamoto, S. Takahashi, 2000, American journal of physiology. Gastrointestinal and liver physiology.

Comparison of the Permeability of Macromolecular Drugs Across Cultured Intestinal and Alveolar Epithelial Cell Monolayers

T. Fujita, A. Yamamoto, S. Muranishi, 2011 .

Functional expression of metabotropic GABAB receptors in primary cultures of astrocytes from rat cerebral cortex.

Qiang Wu, T. Fujita, A. Yamamoto, 2006, Biochemical and biophysical research communications.

Prediction Accuracy of Mechanism-Based Oral Absorption Model for Dogs.

T. Fujita, K. Sugano, Y. Nomura, 2019, Journal of pharmaceutical sciences.

Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors.

T. Fujita, A. Yamamoto, T. Tsuji, 1995, Biological & pharmaceutical bulletin.

Transport of Drugs Across the Xenopus Pulmonary Membrane and Their Absorption Enhancement by Various Absorption Enhancers

T. Fujita, A. Yamamoto, S. Muranishi, 1996, Pharmaceutical Research.

Functional characterization of Zn2+-sensitive GABA transporter expressed in primary cultures of astrocytes from rat cerebral cortex

Qiang Wu, T. Fujita, A. Yamamoto, 2006, Brain Research.

Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. II. In situ and in vitro absorption characteristics of azetirelin from the rat intestine.

T. Fujita, A. Yamamoto, K. Tanaka, 1995, Biological & pharmaceutical bulletin.

Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids.

K. Uemura, T. Fujita, A. Yamamoto, 1994, The Journal of pharmacology and experimental therapeutics.

Calcein is excreted from the intestinal mucosal cell membrane by the active transport system.

T. Fujita, A. Yamamoto, S. Muranishi, 1996, Life sciences.

Functional expression of constitutive nitric oxide synthases regulated by voltage‐gated Na+ and Ca2+ channels in cultured human astrocytes

Y. Itoh, T. Fujita, A. Yamamoto, 2004, Glia.

Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.

T. Fujita, A. Yamamoto, S. Muranishi, 1996, Biological & pharmaceutical bulletin.

Does bacitracin have an absorption-enhancing effect in the intestine?

T. Fujita, A. Yamamoto, S. Muranishi, 1995, Biological & pharmaceutical bulletin.

Effect of Mechanical Agitation on Cationic Liposome Transport across an Unstirred Water Layer in Caco-2 Cells.

T. Fujita, Y. Kono, Kenta Matsuoka, 2016, Biological & pharmaceutical bulletin.

Lymphatic transfer of macromolecules after intrapulmonary administration in the presence or absence of various absorption enhancers in rats.

T. Fujita, A. Yamamoto, S. Muranishi, 1996, Die Pharmazie.

Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.

M. Akashi, S. Nakagawa, T. Fujita, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Carrageenans can regulate the pulmonary absorption of antiasthmatic drugs and their retention in the rat lung tissues without any membrane damage.

T. Fujita, M. Odomi, S. Kohno, 2005, International journal of pharmaceutics.

Two oligopeptide transporters from Caenorhabditis elegans: molecular cloning and functional expression.

V. Ganapathy, T. Fujita, Y. Fei, 1998, The Biochemical journal.

Control of pulmonary absorption of water-soluble compounds by various viscous vehicles.

T. Fujita, A. Yamamoto, S. Muranishi, 2004, International journal of pharmaceutics.

The impact of breast cancer resistant protein (BCRP/ABCG2) on drug transport across Caco-2 cell monolayers.

T. Fujita, A. Yamamoto, Y. Kono, 2020, Drug metabolism and disposition: the biological fate of chemicals.

The Impact of Breast Cancer Resistance Protein (BCRP/ABCG2) on Drug Transport Across Caco-2 Cell Monolayers

T. Fujita, I. Kawahara, Yusuke Kono, 2020 .

Protein Kinase C Regulates the Citrate Transport via Na + -Coupled Citrate Transporter NaCT in HepG2 Cells

T. Fujita, Y. Kono, H. Nishimura, 2020 .

BPB Reports

T. Fujita, Y. Kono, Maya Goto, 2020 .

Effect of Mechanical Agitation on Cationic Liposome Transport across an Unstirred Water Layer in Caco-2 Cells.

T. Fujita, Y. Kono, Kenta Matsuoka, 2016, Biological & pharmaceutical bulletin.

Pharmaceutical and clinical assessment of hydroquinone ointment prepared by extemporaneous nonsterile compounding.

M. Hirai, M. Ichihashi, J. Nordlund, 2002, Biological & pharmaceutical bulletin.

Effects of lipofectin-antigen complexes on major histocompatibility complex class I-restricted antigen presentation pathway in murine dendritic cells and on dendritic cell maturation.

T. Mayumi, T. Fujita, N. Okada, 2001, Biochimica et biophysica acta.

Colon‐specific Delivery of Budesonide with Azopolymer‐coated Pellets: Therapeutic Effects of Budesonide with a Novel Dosage Form against 2,4,6‐Trinitrobenzenesulphonic Acid‐induced Colitis in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1999, The Journal of pharmacy and pharmacology.

Early Differentiation Signatures in Human Induced Pluripotent Stem Cells Determined by Non-Targeted Metabolomics Analysis

T. Fujita, R. Chaleckis, R. Abdalkader, 2023, bioRxiv.

Effect of surface charge, particle size, and modification by polyethylene glycol of liposomes on their association with Caco-2 cells across an unstirred water layer.

T. Fujita, Y. Kono, A. Iwasaki, 2018, Die Pharmazie.

Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants.

S. Nakagawa, H. Mizuguchi, T. Fujita, 2008, Virology.